CoChat

The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on KV7 channels

Open access

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Paracetamol (acetaminophen, APAP) is one of the most frequently used analgesic agents worldwide. It is generally preferred over nonsteroidal anti-inflammatory drugs because it does not cause typical adverse effects resulting from the inhibition of cyclooxygenases, such as gastric ulcers. Nevertheless, inhibitory impact on these enzymes is claimed to contribute to paracetamols mechanisms of action which, therefore, remained controversial. Recently, the APAP metabolites N-arachidonoylaminophenol (AM404) and N-acetyl-p-benzoquinone imine (NAPQI) have been detected in the central nervous system after systemic APAP administration and were reported to mediate paracetamol effects. In contrast to nonsteroidal anti-inflammatory drugs that rather support seizure activity, paracetamol provides anticonvulsant actions, and this dampening of neuronal activity may also form the basis for analgesic effects. Here, we reveal that the APAP metabolite NAPQI, but neither the parent compound nor the metabolite AM404, reduces membrane excitability in rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons. The observed reduction of spike frequencies is accompanied by hyperpolarization in both sets of neurons. In parallel, NAPQI, but neither APAP nor AM404, increases currents through K V 7 channels in DRG and SDH neurons, and the impact on neuronal excitability is absent if K V 7 channels are blocked. Furthermore, NAPQI can revert the inhibitory action of the inflammatory mediator bradykinin on K V 7 channels but does not affect synaptic transmission between DRG and SDH neurons. These results show that the paracetamol metabolite NAPQI dampens excitability of first- and second-order neurons of the pain pathway through an action on K V 7 channels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/j.pain.0000000000001474

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Effects of APAP, AM404 and NAPQI on membrane voltage and excitability of rat DRG and SDH neurons. Dissociated rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons were recorded in perforated current-clamp mode. Baseline values for membrane voltage were recorded during a 150-second application of solvent. Changes in membrane voltage were recorded, whereas the cell was perfused for 600 seconds with either solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons), APAP (100 μM), AM404 (10 μM), or NAPQI (1 μM). To evoke action potentials, current injections in 5 equal increments were made for a period of 2 seconds each, once every 10 seconds. Membrane excitability was evaluated twice, once before the evaluation of the membrane voltage (in presence of solvent) and once subsequent to that (in presence of DMSO, APAP, AM404, or NAPQI). (A) Shows representative traces in the presence of solvent (ctrl, black trace), and NAPQI (gray trace) after 600 seconds in DRG (left panel) and SDH (right panel) neurons. (B) Displays the relation between amplitudes of injected currents and the resulting number of action potentials (no of spikes) under control conditions in 24 DRG (left) as well as 24 SDH (right) neurons. (C) Presents time courses of changes in membrane voltage (Δ voltage) and corresponding changes in action potential numbers (no. of spikes) for DRG (left panels) and SDH (right panels) neurons. The gray-shaded areas indicate the presence of the respective compound: DMSO (DM), paracetamol (APAP, AP), AM404 (AM), and NAPQI (NA). Before the application of a compound, the baseline was recorded in solvent (0.02% DMSO for DRG and 0.08% DMSO for SDH neurons). (D) Exhibits statistical analyses of changes in membrane voltage (Δ voltage) and number of action potentials (normalized spikes) in presence of the respective compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA). *, **Significant differences vs solvent after 600 seconds of perfusion at p < 0.05 and p < 0.01, respectively (Kruskal–Wallis test, Dunn's multiple comparison post hoc test, n = 6). NAPQI, N-acetyl-p-benzoquinone imine.
Figure 1. Effects of APAP, AM404 and NAPQI on membrane voltage and excitability of rat DRG and SDH neurons. Dissociated rat dorsal root ganglion (DRG) and spinal dorsal horn (SDH) neurons were recorded in perforated current-clamp mode. Baseline values for membrane voltage were recorded during a 150-second application of solvent. Changes in membrane voltage were recorded, whereas the cell was perfused for 600 seconds with either solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons), APAP (100 μM), AM404 (10 μM), or NAPQI (1 μM). To evoke action potentials, current injections in 5 equal increments were made for a period of 2 seconds each, once every 10 seconds. Membrane excitability was evaluated twice, once before the evaluation of the membrane voltage (in presence of solvent) and once subsequent to that (in presence of DMSO, APAP, AM404, or NAPQI). (A) Shows representative traces in the presence of solvent (ctrl, black trace), and NAPQI (gray trace) after 600 seconds in DRG (left panel) and SDH (right panel) neurons. (B) Displays the relation between amplitudes of injected currents and the resulting number of action potentials (no of spikes) under control conditions in 24 DRG (left) as well as 24 SDH (right) neurons. (C) Presents time courses of changes in membrane voltage (Δ voltage) and corresponding changes in action potential numbers (no. of spikes) for DRG (left panels) and SDH (right panels) neurons. The gray-shaded areas indicate the presence of the respective compound: DMSO (DM), paracetamol (APAP, AP), AM404 (AM), and NAPQI (NA). Before the application of a compound, the baseline was recorded in solvent (0.02% DMSO for DRG and 0.08% DMSO for SDH neurons). (D) Exhibits statistical analyses of changes in membrane voltage (Δ voltage) and number of action potentials (normalized spikes) in presence of the respective compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA). *, **Significant differences vs solvent after 600 seconds of perfusion at p < 0.05 and p < 0.01, respectively (Kruskal–Wallis test, Dunn's multiple comparison post hoc test, n = 6). NAPQI, N-acetyl-p-benzoquinone imine.CC BY · PubMed Central
Figure 2. Effects of APAP, AM404, and NAPQI on currents through KV7 channels in rat DRG and SDH neurons. Currents through KV7 channels were recorded in perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of KV7 channel activity. Baseline current levels in presence of solvent (DM, 0.1% DMSO in DRG neurons, 0.16% DMSO in SDH neurons) were recorded for 120 seconds, followed by application of paracetamol (APAP, AP, 100 μM), AM404 (AM, 10 μM), or NAPQI (NA, 10 μM) for 600 seconds. (A) A 180-second washout period followed the application of NAPQI; XE991 (3 μM) was applied for 180 seconds at the end of all recordings. All amplitudes were normalized to the average of the first 5 current amplitudes. (A) Displays representative KV7 current traces in the presence of solvent (ctrl, black trace), NAPQI (NA, light gray trace), and XE991 (XE, dark gray trace) in DRG (left panel) and SDH (right panel) neurons. (B) Shows time courses of KV7 currents normalized to the first control values in the presence of the respective compounds in DRG (left panel) and SDH (right panel) neurons indicated by the light gray-shaded area. Solvent (DMSO 0.1% for DRG and DMSO 0.16% for SDH neurons) was present in absence of the respective compounds. XE991 (3 µM) was applied for 180 seconds at the end of all recordings, indicated by the dark gray area, to verify the recording of currents through KV7 channels. (C) Exhibits the statistical analysis of normalized KV7 currents (fold change) after 600 seconds of application of the indicated compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA) in DRG (left panel) and SDH neurons (right panel). *Significant differences vs solvent (DM) at p < 0.05 (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.
Figure 2. Effects of APAP, AM404, and NAPQI on currents through KV7 channels in rat DRG and SDH neurons. Currents through KV7 channels were recorded in perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of KV7 channel activity. Baseline current levels in presence of solvent (DM, 0.1% DMSO in DRG neurons, 0.16% DMSO in SDH neurons) were recorded for 120 seconds, followed by application of paracetamol (APAP, AP, 100 μM), AM404 (AM, 10 μM), or NAPQI (NA, 10 μM) for 600 seconds. (A) A 180-second washout period followed the application of NAPQI; XE991 (3 μM) was applied for 180 seconds at the end of all recordings. All amplitudes were normalized to the average of the first 5 current amplitudes. (A) Displays representative KV7 current traces in the presence of solvent (ctrl, black trace), NAPQI (NA, light gray trace), and XE991 (XE, dark gray trace) in DRG (left panel) and SDH (right panel) neurons. (B) Shows time courses of KV7 currents normalized to the first control values in the presence of the respective compounds in DRG (left panel) and SDH (right panel) neurons indicated by the light gray-shaded area. Solvent (DMSO 0.1% for DRG and DMSO 0.16% for SDH neurons) was present in absence of the respective compounds. XE991 (3 µM) was applied for 180 seconds at the end of all recordings, indicated by the dark gray area, to verify the recording of currents through KV7 channels. (C) Exhibits the statistical analysis of normalized KV7 currents (fold change) after 600 seconds of application of the indicated compounds (DMSO, DM; APAP, AP; AM404, AM; and NAPQI, NA) in DRG (left panel) and SDH neurons (right panel). *Significant differences vs solvent (DM) at p < 0.05 (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.CC BY · PubMed Central
Figure 3. Effects of NAPQI on currents through native rat and recombinant human KV7 channels. Currents through KV7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset, and end of this hyperpolarization-induced current relaxation was taken as the readout of KV7 channel activity. (A) Baseline was recorded in presence of solvent (0.1% DMSO in DRG neurons and tsA201 cells, or 0.16% DMSO in SDH neurons) for a period of 120 seconds, followed by different concentrations of NAPQI (0.1, 1, and 10 µM, as indicated) for 600 seconds, washout for 180 seconds and application of XE991 (3 μM) for 180 seconds. All amplitudes were normalized to the average of the first 5 current amplitudes in presence of the appropriate solvent. (A) Displays time courses of KV7 currents, normalized to control values, and changes in the presence of NAPQI applied at concentrations of 0.1 μM (circles), 1 μM (squares), and 10 μM (triangles) as indicated by the gray-shaded area in DRG (top panel) and SDH (bottom panel) neurons. (B) Exhibits the statistical analysis of KV7 currents, normalized to control values (fold change), at the end of a 600-second application of the indicated NAPQI concentration in DRG (top panel) and SDH (bottom panel) neurons. *, **Significant differences vs 10 µM NAPQI at P < 0.05 and P < 0.01, respectively. ns indicates no significant difference (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). (C) Shows time courses of currents through heteromeric human KV7.2 and KV7.3 (hKv7.2/7.3) channels expressed in tsA201 cells (left panel). Cells were perfused with solvent (0.1% DMSO, circles; n = 6) or NAPQI (1 µM, squares; n = 6) for 600 seconds, as indicated by the gray-shaded area. The right panel shows representative current traces in presence of solvent (0.1% DMSO, ctrl, black trace), NAPQI (1 µM, NA, light gray trace), or XE991 (3 µM, XE, dark gray trace). *Significant difference of normalized KV7 current amplitudes: DMSO (0.91 ± 0.08) vs NAPQI 1 µM (1.29 ± 0.16) at p < 0.05 (Mann–Whitney test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.
Figure 3. Effects of NAPQI on currents through native rat and recombinant human KV7 channels. Currents through KV7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 30 seconds. The difference in amplitude determined at the onset, and end of this hyperpolarization-induced current relaxation was taken as the readout of KV7 channel activity. (A) Baseline was recorded in presence of solvent (0.1% DMSO in DRG neurons and tsA201 cells, or 0.16% DMSO in SDH neurons) for a period of 120 seconds, followed by different concentrations of NAPQI (0.1, 1, and 10 µM, as indicated) for 600 seconds, washout for 180 seconds and application of XE991 (3 μM) for 180 seconds. All amplitudes were normalized to the average of the first 5 current amplitudes in presence of the appropriate solvent. (A) Displays time courses of KV7 currents, normalized to control values, and changes in the presence of NAPQI applied at concentrations of 0.1 μM (circles), 1 μM (squares), and 10 μM (triangles) as indicated by the gray-shaded area in DRG (top panel) and SDH (bottom panel) neurons. (B) Exhibits the statistical analysis of KV7 currents, normalized to control values (fold change), at the end of a 600-second application of the indicated NAPQI concentration in DRG (top panel) and SDH (bottom panel) neurons. *, **Significant differences vs 10 µM NAPQI at P < 0.05 and P < 0.01, respectively. ns indicates no significant difference (Kruskal–Wallis test, Dunn's multiple comparison post hoc test) (n = 6). (C) Shows time courses of currents through heteromeric human KV7.2 and KV7.3 (hKv7.2/7.3) channels expressed in tsA201 cells (left panel). Cells were perfused with solvent (0.1% DMSO, circles; n = 6) or NAPQI (1 µM, squares; n = 6) for 600 seconds, as indicated by the gray-shaded area. The right panel shows representative current traces in presence of solvent (0.1% DMSO, ctrl, black trace), NAPQI (1 µM, NA, light gray trace), or XE991 (3 µM, XE, dark gray trace). *Significant difference of normalized KV7 current amplitudes: DMSO (0.91 ± 0.08) vs NAPQI 1 µM (1.29 ± 0.16) at p < 0.05 (Mann–Whitney test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.CC BY · PubMed Central
Figure 4. Linopirdine blocks the NAPQI-induced reduction in excitability and hyperpolarization in rat DRG and SDH neurons. Membrane voltage and excitability were recorded in perforated current-clamp mode. Baseline values for membrane potential and excitability were determined during a 100-second application of solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons). This was followed by application of linopirdine alone (30 μM) for 150 seconds; the linopirdine-evoked depolarization was then compensated individually for each cell by current injection (indicated by the arrowhead in A) and a stable baseline was recorded for 150 seconds in the continuous presence of linopirdine. In DRG neurons, either NAPQI (1 µM) alone or in combination with the TRPV1 blocker AMG 9810 (100 nM) and the TRPA1 blocker HC 030031 (30 μΜ) was added for 600 seconds as indicated by the dark gray area. In SDH neurons, only NAPQI (1 µM) was present during the 600-second period indicated by the gray area. Membrane excitability was tested twice by injecting 5 equal increments of currents for a period of 2 seconds, once every 10 seconds, before and after the application of NAPQI for 600 seconds. (A) Shows time courses of changes in membrane voltage (left) in DRG (top) and SDH (bottom) neurons in the presence of linopirdine and with addition of NAPQI, either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons). (B) Shows the total number of action potentials in presence of linopirdine with compensated membrane potential before (adjusted, black circles) and at the end of a 600-second application of NAPQI (black triangles) either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons; p > 0.05 in each case, Wilcoxon matched-pairs signed rank test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.
Figure 4. Linopirdine blocks the NAPQI-induced reduction in excitability and hyperpolarization in rat DRG and SDH neurons. Membrane voltage and excitability were recorded in perforated current-clamp mode. Baseline values for membrane potential and excitability were determined during a 100-second application of solvent (0.02% DMSO in DRG neurons and 0.08% DMSO in SDH neurons). This was followed by application of linopirdine alone (30 μM) for 150 seconds; the linopirdine-evoked depolarization was then compensated individually for each cell by current injection (indicated by the arrowhead in A) and a stable baseline was recorded for 150 seconds in the continuous presence of linopirdine. In DRG neurons, either NAPQI (1 µM) alone or in combination with the TRPV1 blocker AMG 9810 (100 nM) and the TRPA1 blocker HC 030031 (30 μΜ) was added for 600 seconds as indicated by the dark gray area. In SDH neurons, only NAPQI (1 µM) was present during the 600-second period indicated by the gray area. Membrane excitability was tested twice by injecting 5 equal increments of currents for a period of 2 seconds, once every 10 seconds, before and after the application of NAPQI for 600 seconds. (A) Shows time courses of changes in membrane voltage (left) in DRG (top) and SDH (bottom) neurons in the presence of linopirdine and with addition of NAPQI, either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons). (B) Shows the total number of action potentials in presence of linopirdine with compensated membrane potential before (adjusted, black circles) and at the end of a 600-second application of NAPQI (black triangles) either alone (top and bottom) or together with TRP blockers (middle; n = 6 for DRG and n = 8 for SDH neurons; p > 0.05 in each case, Wilcoxon matched-pairs signed rank test). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine; SDH, spinal dorsal horn.CC BY · PubMed Central
Figure 5. Application of NAPQI has no effect on synaptic activity in the rat spinal dorsal horn. Recordings were performed in lamina I neurons with monosynaptic C-fiber input in transversal spinal cord slices. (A) Shows original traces of C-fiber-eEPSCs recorded before and at the end of application of either NAPQI (NA) or NAPQI plus CNQX (NA + CN). (B) Displays the time course of normalized C-fiber-eEPSC amplitudes in lamina I neurons. Baseline was recorded for 150 seconds followed by application of NAPQI (10 µM) for 600 seconds (n = 7, p > 0.05 at the end of 600 seconds NAPQI compared with baseline). Bath application of CNQX (10 µM) blocked synaptic transmission at C-fiber synapses (n = 7, P < 0.05, one-way ANOVA at the end of 1200-second NAPQI + CNQX vs baseline). (C) Shows representative traces of sEPSCs at a holding potential of −70 mV before (top; ctrl), at the end of NAPQI application (middle), and at the end of NAPQI + CNQX (bottom). (D) Depicts the statistical analysis of the effects of NAPQI on amplitudes and frequencies of spontaneous EPSCs (sEPSCs) in the same lamina I neurons as in (B) determined at the end of 600-second NAPQI application (n = 7; p > 0.05 in both, one-sample t test). ANOVA, analysis of variance; NAPQI, N-acetyl-p-benzoquinone imine; sEPSCs, spontaneous excitatory postsynaptic currents.
Figure 5. Application of NAPQI has no effect on synaptic activity in the rat spinal dorsal horn. Recordings were performed in lamina I neurons with monosynaptic C-fiber input in transversal spinal cord slices. (A) Shows original traces of C-fiber-eEPSCs recorded before and at the end of application of either NAPQI (NA) or NAPQI plus CNQX (NA + CN). (B) Displays the time course of normalized C-fiber-eEPSC amplitudes in lamina I neurons. Baseline was recorded for 150 seconds followed by application of NAPQI (10 µM) for 600 seconds (n = 7, p > 0.05 at the end of 600 seconds NAPQI compared with baseline). Bath application of CNQX (10 µM) blocked synaptic transmission at C-fiber synapses (n = 7, P < 0.05, one-way ANOVA at the end of 1200-second NAPQI + CNQX vs baseline). (C) Shows representative traces of sEPSCs at a holding potential of −70 mV before (top; ctrl), at the end of NAPQI application (middle), and at the end of NAPQI + CNQX (bottom). (D) Depicts the statistical analysis of the effects of NAPQI on amplitudes and frequencies of spontaneous EPSCs (sEPSCs) in the same lamina I neurons as in (B) determined at the end of 600-second NAPQI application (n = 7; p > 0.05 in both, one-sample t test). ANOVA, analysis of variance; NAPQI, N-acetyl-p-benzoquinone imine; sEPSCs, spontaneous excitatory postsynaptic currents.CC BY · PubMed Central
Figure 6. NAPQI abolishes bradykinin-mediated inhibition of currents through KV7 channels in rat DRG neurons. Currents through KV7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 15 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of KV7 channel activity. (A) Shows a time course of normalized currents through KV7 channels recorded in DRG neurons. Baseline current levels in presence of solvent (0.01% DMSO; DM) were recorded for 45 seconds followed by application of bradykinin (Bk, 10 nM) in the continued presence of solvent (empty circles and squares). Ninety seconds after the onset of Bk application, solvent was either replaced by NAPQI (NA, 1 µM, filled circles), or continuously coapplied together with bradykinin as indicated by the gray-shaded area. All amplitudes were normalized to the average of the first 4 current amplitudes in presence of solvent only. (B) Presents the statistical analysis of normalized KV7 currents (fold change) after 210 seconds of co-application of either Bk + solvent or Bk + NAPQI. *Significant differences vs solvent at p < 0.05 (Mann–Whitney test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine.
Figure 6. NAPQI abolishes bradykinin-mediated inhibition of currents through KV7 channels in rat DRG neurons. Currents through KV7 channels were recorded in the perforated voltage-clamp mode. The cells were clamped to −30 mV and hyperpolarized to −70 mV for a period of 1 second, once every 15 seconds. The difference in amplitude determined at the onset and end of this hyperpolarization-induced current relaxation was taken as the readout of KV7 channel activity. (A) Shows a time course of normalized currents through KV7 channels recorded in DRG neurons. Baseline current levels in presence of solvent (0.01% DMSO; DM) were recorded for 45 seconds followed by application of bradykinin (Bk, 10 nM) in the continued presence of solvent (empty circles and squares). Ninety seconds after the onset of Bk application, solvent was either replaced by NAPQI (NA, 1 µM, filled circles), or continuously coapplied together with bradykinin as indicated by the gray-shaded area. All amplitudes were normalized to the average of the first 4 current amplitudes in presence of solvent only. (B) Presents the statistical analysis of normalized KV7 currents (fold change) after 210 seconds of co-application of either Bk + solvent or Bk + NAPQI. *Significant differences vs solvent at p < 0.05 (Mann–Whitney test) (n = 6). DRG, dorsal root ganglion; NAPQI, N-acetyl-p-benzoquinone imine.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 39

Metadata

Authors
Ray, S., Salzer, I., Kronschläger, M. T., & Boehm, S.
Affiliations
Medical University of Vienna (AT)
Corresponding author
Boehm, Stefan
Venue
Pain
Published
2018-12-28
Volume
160
Issue
4
Pages
954-964
ISSN
  • 0304-3959 (ISSN-L)
  • 1872-6623
OpenAlex
W2907714915
Cited by
35
References
58
Citations by year
2026: 4 · 2025: 8 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 1
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Pain (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
Keywords
paracetamol, N-acetyl-p-benzoquinone imine, AM404, Kv7 channels, neuronal excitability, dorsal root ganglion neurons, dorsal horn, bradykinin, analgesia, pain pathways, cyclooxygenase inhibition, hyperpolarization, synaptic transmission
MeSH terms
Animals, Animals, Newborn, Bradykinin, Capsaicin, Cells, Cultured, Dose-Response Relationship, Drug, Female, Humans, Imines, Male, Pregnancy, Sensory Receptor Cells, Spinal Cord, Transfection, Signal Transduction, Benzoquinones, Rats, Sprague-Dawley, Patch-Clamp Techniques, Analgesics, Non-Narcotic, Excitatory Postsynaptic Potentials, Potassium Channel Blockers, Rats, KCNQ1 Potassium Channel, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on KV7 channels. https://app.cochat.ai/papers/10.1097/j.pain.0000000000001474
The paper
Ray, S., Salzer, I., Kronschläger, M. T., & Boehm, S. (2019). The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on KV7 channels. Pain. https://doi.org/10.1097/j.pain.0000000000001474

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.